BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29603817)

  • 1. Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy.
    Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; George J; Zekry A; Maher L
    J Clin Nurs; 2018 Jul; 27(13-14):2673-2683. PubMed ID: 29603817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study.
    Ramírez Mena A; Thiam M; Ka D; Niang I; Tine J; Fortes L; Ndiaye K; Ndiaye O; Fall M; Gaye A; Ngom NF; Fall F; Berzigotti A; Kirk GD; Jaquet A; Seydi M; Wandeler G;
    Lancet Gastroenterol Hepatol; 2024 Jun; 9(6):539-549. PubMed ID: 38588691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
    Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
    Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of hepatocellular carcinoma in the Asia-Pacific region: consensus statements.
    Asia-Pacific Working Party on Prevention of Hepatocellular Carcinoma
    J Gastroenterol Hepatol; 2010 Apr; 25(4):657-63. PubMed ID: 20492323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
    Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
    JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
    Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
    J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma in western Sydney. Aetiology, changes in incidence, and opportunities for better outcomes.
    Brotodihardjo AE; Tait N; Weltman MD; Liddle C; Little JM; Farrell GC
    Med J Aust; 1994 Oct; 161(7):433-5. PubMed ID: 7935098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
    Chen CF; Lee WC; Yang HI; Chang HC; Jen CL; Iloeje UH; Su J; Hsiao CK; Wang LY; You SL; Lu SN; Chen CJ;
    Gastroenterology; 2011 Oct; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis B virus infection.
    Raimondo G; Balsano C; Craxì A; Farinati F; Levrero M; Mondelli M; Pollicino T; Squadrito G; Tiribelli C
    Dig Liver Dis; 2000 Dec; 32(9):822-6. PubMed ID: 11215565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma not related to hepatitis B virus infection among Alaska natives.
    Chung YH; Di Bisceglie AM; McMahon BJ; Lanier AP; Harpster A; Alter MJ; Parkinson AJ; Zanis C
    Int J Circumpolar Health; 1999 Jul; 58(3):208-13. PubMed ID: 10528471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region.
    Amarapurkar D; Han KH; Chan HL; Ueno Y;
    J Gastroenterol Hepatol; 2009 Jun; 24(6):955-61. PubMed ID: 19383082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the clinical characteristics among hepatocellular carcinoma of hepatitis B, hepatitis C and non-B non-C patients.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2022-7. PubMed ID: 14696457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxin exposure in viral hepatitis patients in Turkey.
    Mizrak D; Engin B; Onder FO; Yener B; Bektaş M; Biyikli Z; Idilman R; Cinar K; Karayalçin K; Ersöz S; Karayalçin S; Ozden A; Yurdaydin C; Yazihan N; Ataoğlu H; Bozkaya H; Uzunalimoğlu O
    Turk J Gastroenterol; 2009 Sep; 20(3):192-7. PubMed ID: 19821201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community.
    Wang JH; Chang KC; Kee KM; Chen PF; Yen YH; Tseng PL; Kuo YH; Tsai MC; Hung CH; Chen CH; Tai WC; Tsai LS; Chen SC; Lin SC; Lu SN
    Am J Gastroenterol; 2013 Mar; 108(3):416-24. PubMed ID: 23318478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
    Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
    Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area.
    Huang YH; Wu JC; Chen CH; Chang TT; Lee PC; Chau GY; Lui WY; Chang FY; Lee SD
    Liver Int; 2005 Apr; 25(2):236-41. PubMed ID: 15780044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
    Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
    J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B.
    Goldberg DS; Valderrama A; Kamalakar R; Sansgiry SS; Babajanyan S; Lewis JD
    J Viral Hepat; 2015 Sep; 22(9):727-36. PubMed ID: 25581816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.